From Molecular Drivers to Clinical Translation of New Biomarkers in MASLD, MASH, and MASLD‑HCC. (IMAGE)
Caption
The schematic diagram links key MASLD, MASH, and MASLD-HCC molecular drivers to emerging multi‑omics biomarkers and therapeutic modalities, highlighting the current barriers in clinical translation and strategic solutions aimed at refined risk stratification and personalized medicine.
Credit
©Science China Press
Usage Restrictions
use with credit.
License
Original content